• Login
  • |
  • Register

NGS Leaders Blog

23andMe Offers the $1,000 Exome

 Permanent link

Davies_pic September 29, 2011  

Kevin Davies :  Ever since its launch in 2007, the personal genomics company 23andMe co-founders Anne Wojcicki and Linda Avey made no secret of their plans to offer their clients access to their individual genome sequence once the technology matured and the price dropped sufficiently.

A significant step came earlier this week, when 23andMe announced it would soon begin offering a $999 exome sequencing service, first come first served. The exome is just a small percentage of one’s total genome sequence, but it’s still a major leap forward for a company that has only offered genotyping until now.
23andMe Exome 80x 

23andMe isn’t trumpeting the news as much as one might have expected, in part because this information will be overkill to a large majority of 23andMe’s 100,000 (and counting) customers. As the company notes:

“The exome sequencing pilot is the first of its kind, and it is suitable for customers who are comfortable managing and understanding raw genetic data. If you don't know your exons from your introns, this pilot is probably not for you. This is for early adopters and supplies are limited.”

The company adds: “You'll be a trailblazer, one of the first people on the planet to know their personal exome sequence!”

23andMe anticipates taking its first orders soon.

I-Study: Genomic Interpretation - Who Will Pay?
During this webinar, members of the study review team present preliminary findings of the I-Study, conducted at the Harvard Medical School's 2011 Personalized Medicine Conference.
Twitter Feed
Privacy Policy|Terms of Use